Cetuximab-conjugated magneto-fluorescent silica nanoparticles for in vivo colon cancer targeting and imaging

Cancer Letters

Volumn 299, Issue 1, 2010, Pages 63-71

  Cho, Young Seok ^a   Yoon, Tae Jong ^b   Jang, Eue Soon ^c   Soo Hong, Kwan ^d   Young Lee, Shin ^a   Ran Kim, Ok ^a   Park, Cheongsoo ^d   Kim, Yong Jin ^e   Yi, Gyu Chul ^e   Chang, Kiyuk ^a  

^a The Catholic University of Korea   (South Korea)

^b CHA University   (South Korea)

^c Kumoh National Institute of Technology   (South Korea)

^d Korea Basic Science Institute (KBSI)   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

Cetuximab; Colon cancer; Molecular imaging; Nanoparticles

Indexed keywords

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; MAGNETIC NANOPARTICLE; SILICON DIOXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; MONOCLONAL ANTIBODY; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE; COLON CANCER; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG UPTAKE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VIVO STUDY; MAGNETIC FIELD; MALE; MOLECULAR IMAGING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL DETECTION; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; COLONIC NEOPLASMS; FLUORESCENCE; MAGNETISM; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; COLONIC NEOPLASMS; FLUORESCENCE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETICS; MALE; MICE; MICE, INBRED BALB C; NANOPARTICLES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SILICON DIOXIDE; ANTIBODIES, MONOCLONAL, HUMANIZED; CETUXIMAB;

EID: 77957891716     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.08.004     Document Type: Article

References (32)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M.J. Cancer statistics, 2008. CA Cancer J. Clin. 2008, 58:71-96.
2. Van Cutsem E., Köhne C.H., Hitre E., Zaluski J., Chang Chien C.R., Makhson A., D'Haens G., Pintér T., Lim R., Bodoky G., Roh J.K., Folprecht G., Ruff P., Stroh C., Tejpar S., Schlichting M., Nippgen J., Rougier P. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. New Engl. J. Med. 2009, 360:1408-1417.
3. Su C.H., Sheu H.S., Lin C.Y., Huang C.C., Lo Y.W., Pu Y.C., Weng J.C., Shieh D.B., Chen J.H., Yeh C.S. Nanoshell magnetic resonance imaging contrast agents. J. Am. Chem. Soc. 2007, 129:2139-2146.
4. Yoon T.J., Kim J.S., Kim B.G., Yu K.N., Cho M.H., Lee J.K. Multifunctional nanoparticles possessing a " magnetic motor effect" for drug or gene delivery. Angew. Chem. Int. Ed. Engl. 2005, 44:1068-1071.
5. Yoon T.Y., Yu K.N., Kim E., Kim J.S., Kim B.G., Yun S.H., Sohn B.H., Cho M.H., Lee J.K., Park S.B. Specific targeting, cell sorting, and bioimaging with smart magnetic silica core-shell nanomaterials. Small 2006, 2:209-215.
6. Weissleder R. Molecular imaging in cancer. Science 2006, 312:1168-1171.
7. Lee J.H., Huh Y.M., Jun Y.W., Seo J.W., Jang J.T., Song H.T., Kim S., Cho E.J., Yoon H.G., Suh J.S., Cheon J. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat. Med. 2007, 13:95-99.
8. Moore A., Josephson L., Bhorade R.M., Basilion J.P., Weissleder R. Human transferrin receptor gene as a marker gene for MR imaging. Radiology 2001, 221:244-250.
9. Choi H., Choi S.R., Zhou R., Kung H.F., Chen I.W. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. Acad. Radiol. 2004, 11:996-1004.
10. Nasongkla N., Bey E., Ren J., Ai H., Khemtong C., Guthi J.S., Chin S.F., Sherry A.D., Boothman D.A., Gao J. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett. 2006, 6:2427-2430.
11. Medarova Z., Pham W., Kim Y., Dai G., Moore A. In vivo imaging of tumor response to therapy using a dual-modality imaging strategy. Int. J. Cancer 2006, 118:2796-2802.
12. Simberg D., Duza T., Park J.H., Essler M., Pilch J., Zhang L., Derfus A.M., Yang M., Hoffman R.M., Bhatia S., Sailor M.J., Ruoslahti E. Biomimetic amplification of nanoparticle homing to tumors. Proc. Natl. Acad. Sci. USA 2007, 104:932-936.
13. Messa C., Russo F., Caruso M.G., Di Leo A. EGF, TGF-alpha, and EGF-R in human colorectal adenocarcinoma. Acta Oncol. 1998, 37:285-289.
14. Porebska I., Harlozińska A., Bojarowski T. Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2, ERB B3) in colorectal adenocarcinomas and adenomas. Tumour Biol. 2000, 21:105-115.
15. Goldstein N.S., Armin M. Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: implications for a standardized scoring system. Cancer 2001, 92:1331-1346.
16. Tseng C.L., Wang T.W., Dong G.C., Yueh-Hsiu Wu S., Young T.H., Shieh M.J., Lou P.J., Lin F.H. Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting. Biomaterials 2007, 28:3996-4005.
17. Ke S., Wen X., Gurfinkel M., Charnsangavej C., Wallace S., Sevick-Muraca E.M., Li C. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res. 2003, 63:7870-7875.
18. Goldstein N.I., Prewett M., Zuklys K., Rockwell P., Mendelsohn J. Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in human tumor xenograft model. Clin. Cancer Res. 1995, 1:1311-1318.
19. Ciardiello F., Tortora G. EGFR antagonists in cancer treatment. New Engl. J. Med. 2008, 358:1160-1174.
20. Yang J., Lim E.K., Lee H.J., Park J., Lee S.C., Lee K., Yoon H.G., Suh J.S., Huh Y.M., Haam S. Fluorescent magnetic nanohybrids as multimodal imaging agents for human epithelial cancer detection. Biomaterials 2008, 29:2548-2555.
21. Zins D., Cabuil V., Massart R. New aqueous magnetic fluids. J. Mol. Liq. 1999, 83:217-232.
22. Sousa M.H., Tourinho F.A., Depeyrot J., da Silva G.J., Lara M.C.F.L. New electric double-layered magnetic fluids based on copper, nickel, and zinc ferrite nanostructures. J. Phys. Chem. B 2001, 105:1168-1175.
23. Saul J.M., Annapragada A., Natarajan J.V., Bellamkonda R.V. Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J. Control. Release 2003, 92:49-67.
24. Gao X., Cui Y., Levenson R.M., Chung L.W., Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 2004, 22:969-976.
25. Wilhelm C., Lavialle F., Péchoux C., Tatischeff I., Gazeau F. Intracellular trafficking of magnetic nanoparticles to design multifunctional biovesicles. Small 2008, 4:577-582.
26. Chithrani B.D., Chan W.C. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 2007, 7:1542-1550.
27. Herbig M.E., Assi F., Textor M., Merkle H.P. The cell penetrating peptides pVEC and W2-pVEC induce transformation of gel phase domains in phospholipid bilayers without affecting their integrity. Biochemistry 2006, 45:3598-3609.
28. Kang B., Mackey M.A., El-Sayed M.A. Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. J. Am. Chem. Soc. 2010, 132:1517-1519.
29. He Q., Zhang Z., Gao Y., Shi J., Li Y. Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles. Small 2009, 5:2722-2729.
30. He X., Nie H., Wang K., Tan W., Wu X., Zhang P. In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles. Anal. Chem. 2008, 80:9597-9603.
31. Burns A.A., Vider J., Ow H., Herz E., Penate-Medina O., Baumgart M., Larson S.M., Wiesner U., Bradbury M. Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett. 2009, 9:442-448.
32. Dobson J. Magnetic nanoparticle for drug delivery. Drug Dev. Res. 2007, 67:55-60.